Pennsylvania Business Report

Newtown-based Traws Pharma advances experimental antiviral therapy

Featured
By Kim Riley  |  May 28, 2026

Traws Pharma Inc. said May 27 that it is advancing development of a proprietary broad-spectrum antiviral combination therapy aimed at combating deadly viruses, including Hantavirus, Ebola, and Lassa fever. The clinical-stage biopharmaceutical company, which is headquartered in Newtown, Pa., said the investigational treatment uses a “dual-strike” mechanism designed to disrupt how viruses replicate inside human cells.  According to the company, one part of the therapy depletes a host ce...

Read More